Report cover image

Global Castrate-resistant Prostate Cancer Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749863

Description

Global Castrate-resistant Prostate Cancer Databank Market Report


The Castrate-resistant Prostate Cancer market was valued at $8,721.3 Million in 2022, and is projected to reach $15,584.9 Million by 2031 growing at a CAGR of 6.71% from 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. Chemotherapy segment is anticipated to reach $1,192.5 Million by 2031 with the highest CAGR of 8.53%. Hormonal Therapy and Immunotherapy segments collectively expected to account for about 91.4% share of the Castrate-resistant Prostate Cancer market in 2022, with the former constituting around 82.9% share. Chemotherapy and Radiotherapy segments are expected to witness significant growth rates at a CAGR of 8.53% and 8.37% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 8.6% in the overall Castrate-resistant Prostate Cancer market in 2022, and is anticipated to reach 9.9% by 2031.

Table of Contents

100 Pages
1. Global Castrate-resistant Prostate Cancer Market, By Therapy
1.1. Overview
1.2. Chemotherapy
1.2.1 Chemotherapy Market, By Region
1.2.1.1 North America Chemotherapy Market, By Country
1.2.1.2 Europe Chemotherapy Market, By Country
1.2.1.3 Asia-Pacific Chemotherapy Market, By Country
1.2.1.4 Rest of World Chemotherapy Market, By Country
1.3. Hormonal Therapy
1.3.1 Hormonal Therapy Market, By Region
1.3.1.1 North America Hormonal Therapy Market, By Country
1.3.1.2 Europe Hormonal Therapy Market, By Country
1.3.1.3 Asia-Pacific Hormonal Therapy Market, By Country
1.3.1.4 Rest of World Hormonal Therapy Market, By Country
1.4. Immunotherapy
1.4.1 Immunotherapy Market, By Region
1.4.1.1 North America Immunotherapy Market, By Country
1.4.1.2 Europe Immunotherapy Market, By Country
1.4.1.3 Asia-Pacific Immunotherapy Market, By Country
1.4.1.4 Rest of World Immunotherapy Market, By Country
1.5. Radiotherapy
1.5.1 Radiotherapy Market, By Region
1.5.1.1 North America Radiotherapy Market, By Country
1.5.1.2 Europe Radiotherapy Market, By Country
1.5.1.3 Asia-Pacific Radiotherapy Market, By Country
1.5.1.4 Rest of World Radiotherapy Market, By Country
2. Global Castrate-resistant Prostate Cancer Market, By Region
2.1. Overview
2.2. North America
2.2.1 North America Castrate-resistant Prostate Cancer Market, By Therapy
2.2.2 North America Castrate-resistant Prostate Cancer Market, By Country
2.2.2.1 U.S.
2.2.2.1.1 U.S. Castrate-resistant Prostate Cancer Market, By Therapy
2.2.2.2 Canada
2.2.2.2.1 Canada Castrate-resistant Prostate Cancer Market, By Therapy
2.3. Europe
2.3.1 Europe Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2 Europe Castrate-resistant Prostate Cancer Market, By Country
2.3.2.1 Germany
2.3.2.1.1 Germany Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2.2 U.K.
2.3.2.2.1 U.K. Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2.3 France
2.3.2.3.1 France Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2.4 Italy
2.3.2.4.1 Italy Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2.5 Spain
2.3.2.5.1 Spain Castrate-resistant Prostate Cancer Market, By Therapy
2.3.2.6 Rest of Europe
2.3.2.6.1 Rest of Europe Castrate-resistant Prostate Cancer Market, By Therapy
2.4. Asia-Pacific
2.4.1 Asia-Pacific Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2 Asia-Pacific Castrate-resistant Prostate Cancer Market, By Country
2.4.2.1 China
2.4.2.1.1 China Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2.2 Japan
2.4.2.2.1 Japan Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2.3 South Korea
2.4.2.3.1 South Korea Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2.4 India
2.4.2.4.1 India Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2.5 Singapore
2.4.2.5.1 Singapore Castrate-resistant Prostate Cancer Market, By Therapy
2.4.2.6 Rest of Asia
2.4.2.6.1 Rest of Asia Castrate-resistant Prostate Cancer Market, By Therapy
2.5. Rest of World
2.5.1 Rest of World Castrate-resistant Prostate Cancer Market, By Therapy
2.5.2 Rest of World Castrate-resistant Prostate Cancer Market, By Country
2.5.2.1 Brazil
2.5.2.1.1 Brazil Castrate-resistant Prostate Cancer Market, By Therapy
2.5.2.2 Mexico
2.5.2.2.1 Mexico Castrate-resistant Prostate Cancer Market, By Therapy
2.5.2.3 South Africa
2.5.2.3.1 South Africa Castrate-resistant Prostate Cancer Market, By Therapy
2.5.2.4 Australia
2.5.2.4.1 Australia Castrate-resistant Prostate Cancer Market, By Therapy
2.5.2.5 ROW Countries
2.5.2.5.1 ROW Countries Castrate-resistant Prostate Cancer Market, By Therapy
ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 2. Chemotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Hormonal Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 12. Immunotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 17. Radiotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Radiotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 19. Europe Radiotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 20. Asia-Pacific Radiotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 21. Rest of World Radiotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 22. Global Castrate-resistant Prostate Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 23. North America Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 24. North America Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 25. U.S. Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 26. Canada Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 27. Europe Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 28. Europe Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 29. Germany Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 30. U.K. Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 31. France Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 32. Italy Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 33. Spain Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 34. Rest of Europe Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 35. Asia-Pacific Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 36. Asia-Pacific Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 37. China Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 38. Japan Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 39. South Korea Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 40. India Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 41. Singapore Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 42. Rest of Asia Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 43. Rest of World Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 44. Rest of World Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 45. Brazil Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 46. Mexico Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 47. South Africa Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 48. Australia Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
TABLE 49. ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD
ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us